Vulvar Cancers
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASILâ„¢ (V503-006) (NCT01047345) | Merck Sharp & Dohme LLC | 2010-02-24 |
Track Vulvar Cancers automatically
Every clearance here is in the API, with alerts when new ones post.